share_log

Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying

Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying

Gossamer Bio和其他2支股票在$2以下,內部人士正在購買。
Benzinga ·  06/25 08:51

The Dow Jones index closed higher by over 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週一收盤上漲超過250點。當內部人士購買或出售股票時,這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是細價股最近幾筆值得注意的內幕交易。欲了解更多信息,請訪問Benzinga的內幕交易平台。

Pacific Health Care Organization

太平洋醫療保健組織

  • The Trade: Pacific Health Care Organization, Inc. (NASDAQ:PFHO) CEO and President Tom Kubota bought a total of 6,270 shares at an average price of $0.88. To acquire these shares, it cost around $5,543.
  • What's Happening: The company reported net income of $176,427 or $0.01 per share for the three months ended June 30, 2023.
  • What Pacific Health Care Organization Does: Pacific Health Care Organization Inc is a specialty workers' compensation managed care company.
  • 貿易:太平洋醫療保健組織有限公司(納斯達克股票代碼:PFHO)首席執行官兼總裁湯姆·久保田共購買了6,270股股票,平均價格爲0.88美元。收購這些股票的成本約爲5,543美元。
  • 發生了什麼:該公司報告稱,截至2023年6月30日的三個月,淨收益爲176,427美元,合每股收益0.01美元。
  • 太平洋醫療保健組織做什麼:太平洋醫療保健組織公司是一家專業的工人補償管理型醫療公司。

System1

系統 1

  • The Trade: System1, Inc. (NYSE:SST) 10% owner Cee Holdings Trust acquired a total of 8,013 shares at an average price of $1.44. To acquire these shares, it cost around $11,575.
  • What's Happening: On May 9, System1 posted upbeat first-quarter results.
  • What System1 Does: System1 Inc develops technology and data science to operate a responsive acquisition marketing platform.
  • 交易:System1, Inc.(紐約證券交易所代碼:SST)10%的所有者Cee Holdings Trust共收購了8,013股股票,平均價格爲1.44美元。收購這些股票的成本約爲11,575美元。
  • 發生了什麼:5月9日,System1公佈了樂觀的第一季度業績。
  • System1的作用:System1 Inc開發技術和數據科學來運營響應式收購營銷平台。

Gossamer Bio

Gossamer Bio

  • The Trade: Gossamer Bio, Inc. (NASDAQ:GOSS) President and CEO Faheem Hasnain acquired a total of 372,000 shares at an average price of $0.67. The insider spent around $250,282 to buy those shares.
  • What's Happening: On June 25, Oppenheimer analyst Andreas Argyrides initiated coverage on Gossamer Bio with an Outperform rating and announced a price target of $9.
  • What Gossamer Bio Does: Gossamer Bio Inc is a clinical-stage biopharmaceutical company.
  • 交易:Gossamer Bio, Inc.(納斯達克股票代碼:GOSS)總裁兼首席執行官法希姆·哈斯南共收購了37.2萬股股票,平均價格爲0.67美元。知情人士花費了約250,282美元購買了這些股票。
  • 發生了什麼:6月25日,奧本海默分析師安德烈亞斯·阿吉里德斯開始對Gossamer Bio進行報道,評級爲跑贏大盤,並宣佈目標股價爲9美元。
  • Gossamer Bio做什麼:Gossamer Bio Inc是一家臨床階段的生物製藥公司。

Read More: Stocks To Watch On Tuesday: Boeing, FedEx And More

閱讀更多:週二值得關注的股票:波音、聯邦快遞等

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論